Skip to main content
Top
Published in: Ophthalmology and Therapy 2/2019

Open Access 01-06-2019 | Glaucoma | Brief Report

Expediency of the Automated Perimetry Using the Goldmann V Stimulus Size in Visually Impaired Patients with Glaucoma

Authors: Adriana M. Morgan, Livia S. Mazzoli, Cristiano Caixeta-Umbelino, Niro Kasahara

Published in: Ophthalmology and Therapy | Issue 2/2019

Login to get access

Abstract

Introduction

White-on-white standard automated perimetry (AP) uses a white round stimulus with 0.43° diameter and 4.0 mm2 area (Goldmann size III). Patients with low vision have difficulty seeing such a small stimulus and are often tested with perimetry using the size V stimulus with 1.72° diameter and 64 mm2 area. We undertook an observational case-control study to compare the performance of patients on AP using two differently sized stimuli.

Methods

Patients with glaucoma and visual acuity worse than 20/100 underwent AP using the standard size III stimulus Swedish Interactive Threshold Algorithm (SITA) standard test and size V stimulus full threshold test. All patients were familiar with the procedure, having done the test at least twice previously. Another group of glaucoma patients with visual acuity better than 20/40 served as controls. The main outcome measures included test time, mean retinal sensitivity (MRS), foveal sensitivity (FS), fixation loss (FL), false positive (FP), false negative (FN), and the patient's subjective preference.

Results

Fifty patients were included in the study. Most preferred the size V stimulus target size test. For glaucoma patients, test time was shorter with size III; MRS and FS were higher with size V; FL, FP, and FN did not differ between the tests.

Conclusion

AP with stimulus size V may be a good alternative to standard size III in selected visually debilitated patients who report difficulty undergoing a standard SITA 24-2 test.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wall M, Kutzko KE, Chauhan CBC. Variability in patients with glaucomatous visual field damage is reduced using size V stimuli. Invest Ophthalmol Vis Sci. 1997; 38: 426–35.PubMed Wall M, Kutzko KE, Chauhan CBC. Variability in patients with glaucomatous visual field damage is reduced using size V stimuli. Invest Ophthalmol Vis Sci. 1997; 38: 426–35.PubMed
2.
go back to reference Wall M, Brito CF, Woodward KR, Doyle CK, Kardon RH, Johnson CA. Total deviation probability plots for stimulus size V perimetry. A comparison with size III stimuli. Arch Ophthalmol. 2008; 126: 473–9.CrossRef Wall M, Brito CF, Woodward KR, Doyle CK, Kardon RH, Johnson CA. Total deviation probability plots for stimulus size V perimetry. A comparison with size III stimuli. Arch Ophthalmol. 2008; 126: 473–9.CrossRef
3.
go back to reference Wall M, Doyle CK, Eden T, Zamba KD, Johnson CA. Size threshold perimetry performs as well as conventional automated perimetry with stimulus sizes III, V, and VI for glaucomatous loss. Invest Ophthalmol Vis Sci. 2013;54:3975–83.CrossRef Wall M, Doyle CK, Eden T, Zamba KD, Johnson CA. Size threshold perimetry performs as well as conventional automated perimetry with stimulus sizes III, V, and VI for glaucomatous loss. Invest Ophthalmol Vis Sci. 2013;54:3975–83.CrossRef
4.
go back to reference Gardiner SK, Demirel S, Goren D, Mansberger SL, Swanson WH. The effect of stimulus size on the reliable stimulus range of perimetry. Tran Vis Sci Tech. 2015;4:10.CrossRef Gardiner SK, Demirel S, Goren D, Mansberger SL, Swanson WH. The effect of stimulus size on the reliable stimulus range of perimetry. Tran Vis Sci Tech. 2015;4:10.CrossRef
5.
go back to reference Phu J, Khuu SK, Zangerl B, Kalloniatis M. A comparison of Goldmann III, V and spatially equated test stimuli in visual field testing: the importance of complete and partial spatial summation. Ophthalmic Physiol Opt. 2017;37:160–76.CrossRef Phu J, Khuu SK, Zangerl B, Kalloniatis M. A comparison of Goldmann III, V and spatially equated test stimuli in visual field testing: the importance of complete and partial spatial summation. Ophthalmic Physiol Opt. 2017;37:160–76.CrossRef
6.
go back to reference Wall M, Zamba GKD, Artes PH. The effective dynamic ranges for glaucomatous visual field progression with standard automated perimetry and stimulus sizes III and V. Invest Ophthalmol Vis Sci. 2018;59:439–45.CrossRef Wall M, Zamba GKD, Artes PH. The effective dynamic ranges for glaucomatous visual field progression with standard automated perimetry and stimulus sizes III and V. Invest Ophthalmol Vis Sci. 2018;59:439–45.CrossRef
7.
go back to reference Bengtsson B, Heijl A. False-negative responses in glaucoma perimetry: indicators of patient performance or test reliability? Invest Ophthalmol Vis Sci. 2000;41:2201–4.PubMed Bengtsson B, Heijl A. False-negative responses in glaucoma perimetry: indicators of patient performance or test reliability? Invest Ophthalmol Vis Sci. 2000;41:2201–4.PubMed
8.
go back to reference Schaumberger M, Schafer B, Lachenmayr BJ. Glaucomatous visual fields. fastpac versus full tthreshold strategy of the humphrey field analyzer. Invest Ophthalmol Vis Sci. 1995; 36: 1390–7.PubMed Schaumberger M, Schafer B, Lachenmayr BJ. Glaucomatous visual fields. fastpac versus full tthreshold strategy of the humphrey field analyzer. Invest Ophthalmol Vis Sci. 1995; 36: 1390–7.PubMed
9.
go back to reference Bengtsson B, Olsson J, Heijl A, Rootzén H. A new generation of algorithms for computerized threshold perimetry, SITA. Acta Ophthalmol. 1997;75:368–75.CrossRef Bengtsson B, Olsson J, Heijl A, Rootzén H. A new generation of algorithms for computerized threshold perimetry, SITA. Acta Ophthalmol. 1997;75:368–75.CrossRef
10.
go back to reference Choplin NT, Sherwood MB, Spaeth GL. The effect of stimulus size on the measured threshold values in automated perimetry. Ophthalmol. 1990;97:371–4.CrossRef Choplin NT, Sherwood MB, Spaeth GL. The effect of stimulus size on the measured threshold values in automated perimetry. Ophthalmol. 1990;97:371–4.CrossRef
11.
go back to reference Zulauf M, Caprioli J. Indications for stimulus 3 and 5 in automatic perimetry. Prelim Results Klin Monbl Augenheilkd. 1994;204:407–8.CrossRef Zulauf M, Caprioli J. Indications for stimulus 3 and 5 in automatic perimetry. Prelim Results Klin Monbl Augenheilkd. 1994;204:407–8.CrossRef
12.
go back to reference Sloan LL. Area and luminance of test object as variables in examination of the visual field by projection perimetry. Vis Res. 1961;1:121–38.CrossRef Sloan LL. Area and luminance of test object as variables in examination of the visual field by projection perimetry. Vis Res. 1961;1:121–38.CrossRef
13.
go back to reference Swanson WH, Felius J, Birch DG. Effect of stimulus size on static visual fields in patients with retinitis pigmentosa. Ophthalmol. 2000;107:1950–4.CrossRef Swanson WH, Felius J, Birch DG. Effect of stimulus size on static visual fields in patients with retinitis pigmentosa. Ophthalmol. 2000;107:1950–4.CrossRef
Metadata
Title
Expediency of the Automated Perimetry Using the Goldmann V Stimulus Size in Visually Impaired Patients with Glaucoma
Authors
Adriana M. Morgan
Livia S. Mazzoli
Cristiano Caixeta-Umbelino
Niro Kasahara
Publication date
01-06-2019
Publisher
Springer Healthcare
Keyword
Glaucoma
Published in
Ophthalmology and Therapy / Issue 2/2019
Print ISSN: 2193-8245
Electronic ISSN: 2193-6528
DOI
https://doi.org/10.1007/s40123-019-0175-9

Other articles of this Issue 2/2019

Ophthalmology and Therapy 2/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.